Headlines

Merck (MRK) said the study met its primary endpoint of clinical remission according to the Modified Mayo Score at week 12, as well as key secondary endpoints

Newsquawk Staff ·

Merck (MRK) said the study met its primary endpoint of clinical remission according to the Modified Mayo Score at week 12, as well as key secondary endpoints.

Related headlines